Skip to main content
All lobbying filings

THE PROCTER AND GAMBLE COMPANY

THE PROCTER AND GAMBLE COMPANY filed a Q2 report for THE PROCTER AND GAMBLE COMPANY on July 21, 2025.

Lobbying for THE PROCTER AND GAMBLE COMPANY

All filings by THE PROCTER AND GAMBLE COMPANY · Everything THE PROCTER AND GAMBLE COMPANY has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Expenses
$1,320,000
What this organization spent lobbying with its own staff. Reported using IRS section 162(e) definitions (method C): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Lobbying activity 7

-H.R. 1 (One Big Beautiful Bill Act - AI Moratorium)

-Issues related to U.S. Manufacturing

-OECD Digital Tax Project (Global Minimum Tax Implementation) -H.R. 1 (One Big Beautiful Bill Act - Corporate/International Tax Provisions) -S.2003 (Strengthening Benefit Plans Act of 2025)

-Issues related to IEEPA Tariffs -Issues related to the Pharmaceuticals Section 232 Trade Investigation -Issues related to Lumber Section 232 Trade Investigation

-Issues related to product safety

-Issues related to over the counter drug policy -Issues related to ingredient labeling -H.R. 3749(IH) Health and Endocrine Research on Personal Care Products for Women Act* -H.R.4273 To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes

-Issues related to new chemical approvals (no bill)

 Bills named in this filing 4
  • H.R. 1
    One Big Beautiful Bill Act
  • S. 2003
    Strengthening Benefit Plans Act of 2025
  • H.R. 3749
    HER Act
  • H.R. 4273
    Over-the-Counter Monograph Drug User Fee Amendments

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem